Michelle specialises in CRISPR genome engineering with a focus on probiotic bacteria for therapeutic applications. She began her career as a Research Assistant at CUHK, gaining expertise in genetic modification and molecular biology techniques. Currently, she is a research scientist at GeneGuard Life Sciences Co., Ltd., where she designs experiments, conducts practical research, and collaborates with bioinformaticians to advance gene-editing technologies. Passionate about CRISPR innovation, Michelle is dedicated to exploring cutting-edge research with the potential to transform medicine and develop novel therapeutic solutions.